Navigation Links
Marken Strengthens Clinical Trial Distribution Capabilities
Date:1/10/2012

LONDON, Jan. 10, 2012 /PRNewswire/ -- Marken is pleased to announce that Dr. Andrea Zobel has joined Marken in the new role of Senior Director, CTD Operations.  In this capacity she will assume responsibility for all activities within the growing network of Marken operated Clinical Trial Depots once they are completed and qualified for use and also manage the relationship with their affiliate depot network.

(Logo:  http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

Dr. Zobel is a biochemist by training and spent her early career in drug development as an assistant professor at the Institute for Pharmacology, Freie Universitat Berlin then as Head of Preclinical Development at ActinoDrug Pharmaceuticals, Henningsdorf.  Since 2004 Andrea has worked for Parexel International building unparalleled experience as Director Clinical Logistics Europe and Head of Global Center of Excellence Clinical Trial Supply both building and running a business with annual revenues in excess of USD 50 million.   She has a deep knowledge of managing strategic partnerships within the pharmaceutical industry, specialist knowledge in managing clinical trials logistics worldwide but particularly within Europe and a passion for professional Project Management. 

"We are excited to welcome Andrea to our team, her expertise and knowledge of the industry further strengthens the market leadership of Marken's Clinical Trial Distribution service line,"  Marken CEO, Wes Wheeler commented. "Our continued enhancement of our purpose build Pharmaceutical Service Depot network establishes Marken as the clear choice for innovative global clinical supply chain solutions."

Marken the premium provider of lif
'/>"/>

SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Marken Unveils New Japan Office
2. Marken Rapidly Responds to Global Supply Chain Security Measures
3. Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
4. Marken Announces Appointment of Christopher OConnell as New Chief Financial Officer
5. Marken Announces Its New Logistics Operating System: Maestro™
6. Marken Appoints New Head of Global Quality Assurance
7. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
8. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
9. Pepscan Therapeutics Strengthens Management Team
10. Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering
11. Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... und LONDON , July ... , Ziel der Zusammenarbeit sind Entwicklung und Kommerzialisierung ... Plasmaproben zur Steuerung von Therapien mit IRESSA bei ... Neuer Bluttest basiert auf QIAGENs von der ... Rotor-Gene Q, einer Automationsplattform der QIAsymphony-Produktfamilie, laufen  ...
(Date:7/28/2014)... , Germany and ... , Collaboration aims to create and ... to guide the use of IRESSA  for non-small cell ... build on QIAGEN,s FDA-approved  therascreen   EGFR test and is ... of automated instruments  Project enabled by AstraZeneca ...
(Date:7/28/2014)... , July 28, 2014 CTI BioPharma ... it will report its second quarter 2014 financial results ... the U.S. financial markets. Following the announcement, members of ... to discuss the results and provide a general corporate ... to the event can be obtained as follows: ...
Breaking Medicine Technology:QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 2QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 3QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 4QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 5QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 6QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 7QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014 2
... Receiving the herpes zoster vaccine was associated with a ... Kaiser Permanente study of 300,000 people that appears in the ... Association . This retrospective study observed the outcomes ... large, diverse population of men and women ages 60 years ...
... 11, 2011 Celleration, Inc., a privately held medical ... products, today announced the closing of an $8 million ... Company,s existing institutional investors participated in this round in ... a new investor. "The addition of ...
Cached Medicine Technology:Shingles Vaccine Associated With 55 Percent Reduced Risk of Disease 2Shingles Vaccine Associated With 55 Percent Reduced Risk of Disease 3Shingles Vaccine Associated With 55 Percent Reduced Risk of Disease 4
(Date:7/27/2014)... Manufacturers of natural ingredient beauty creams are now ... younger appearance. The Cherry News company has published its ... women explore the availabilities from U.S. retailers at ... the posted guide on the Cherry News website provide ... to some natural ingredient formulas is the high sticker ...
(Date:7/27/2014)... CA (PRWEB) July 27, 2014 Ticket Down ... Tickets at The Forum in Inglewood, California on November 15th. ... and diehard fans can expect to hear songs from this amazing ... of Summer concert in Inglewood, California at The Forum will be ... starting at 10:00 a.m. today local time TicketDown.com. This popular ...
(Date:7/27/2014)... 2014 The constant expansion of companies ... demand for enterprise video. Additional factors that have increased ... areas such as corporate communication, learning and development, security ... all these factors the enterprise video market value has ... reach $35.57 billion in 2018 with a compound annual ...
(Date:7/27/2014)... The report, “Oil Filter & Fuel Filter Market by ... (OE & Aftermarket), Filter Type (Oil & Fuel), Fuel ... & Forecast to 2018”, defines and segments the global ... forecasting of the global volume and revenue. The market ... revenue of $6.1 billion in 2018, while fuel filter ...
(Date:7/27/2014)... European Bromine market report defines and segments the Bromine market ... market in European region comprises of four major countries. They ... forms a dominant share of Bromine market influences the demand ... through the TOC of the Europe Bromine Market report, to ... the TOC of the Europe Bromine Market report. The report ...
Breaking Medicine News(10 mins):Health News:Natural Eye Cream Buyer's Guide Published Online at Consumer News Website 2Health News:5 Seconds of Summer Tickets at The Forum in Inglewood (Los Angeles), CA Now Available For Sale at Ticket Down 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 4Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 2Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 3Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 4Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 5Health News:Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor 4
... muscle, bone behind severity of damage, longer recovery, study finds ... muscles of the lower body appear to be more vulnerable ... new study suggests. , The study analyzed the weight and ... over a three-year period. Sprains, such as to the ankle ...
... ranked among the top competitors in the world for Biathlon competitions. As ... Games to be held in Vancouver, Canada. Lanny and Tracy are crediting ... helping them get the most out of their training. , ... Parsippany, ...
... from Sticky Jewelry make a difference. Sticky J attends the "Walk ... and the Juvenile Diabetes Research Foundation made the day a success. ... ... 2000 Sticky Jewelry (StickyJ.com) has specialized in selling personalized jewelry ...
... of swine flu casesBELIZE CITY, Belize, May 1 ... residents and travelers against the swine flu, which is now ... additional proactive steps towards protection against the pandemic. ... Zone and casinos in the town of Corozal, which borders ...
... SCARBOROUGH, Maine , May 1, Binax, ... diagnostic tests to identify the causative pathogens of infectious ... information has been distributed to customers and potential customers of ... of the BinaxNow(R) Influenza A & B test has not ...
... with cancer that is resistant to standard therapy is the ... obtained in some settings, in many cases the therapies have ... has now been uncovered by a team of researchers, led ... London School of Medicine and Dentistry, London. , In the ...
Cached Medicine News:Health News:Obese Children More Likely to Suffer Lower Body Injuries 2Health News:Twin Sisters Set Their Sights On Biathlon Gold At The 2010 Winter Games 2Health News:Sticky Jewelry & JDRF Team Up to Find a Cure 2Health News:Sticky Jewelry & JDRF Team Up to Find a Cure 3Health News:Belize Takes Further Action Regarding Influenza A (H1N1) to Ensure Safety of Travelers 2
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
Anatomical implants for the entire hand, in five sizes...
... a brief magnetic pulse to stimulate deep ... in Magnetic Nerve Stimulators. Based upon equipment ... in 1985. A powerful monophasic stimulator for ... best stimulator for Central Motor Conduction Studies, ...
Medicine Products: